Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model

Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model

Diabetic cardiovascular complications are associated with up to 50% mortality, and current therapies are not effective enough. Renin–angiotensin–aldosterone system inhibitors (RAASis) are the standard of care for diabetic patients with hypertension and albuminuria. Based on our previous studies repo...

Full description

Bibliographic Details
Main Authors: Dora B. Balogh, Agnes Molnar, Arianna Degi, Akos Toth, Lilla Lenart, Adar Saeed, Adrienn Barczi, Attila J. Szabo, Laszlo J. Wagner, Gyorgy Reusz, Andrea Fekete
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:International Journal of Molecular Sciences
Subjects:
diabetes
diabetic cardiomyopathy
heart failure
renin–angiotensin–aldosterone system inhibitors
myocardial fibrosis
intima–media thickness
Online Access:https://www.mdpi.com/1422-0067/24/23/17043

Internet

https://www.mdpi.com/1422-0067/24/23/17043

Similar Items